Navigation Links
New study shows measles immunization may prevent fatal brain infection

A new study has found wild-type measles virus in tissues from patients who died of a fatal brain infection, providing evidence against the notion that the strain of virus in the measles vaccine caused the infection. The study, in the November 15 issue of The Journal of Infectious Diseases, now available online, also concludes that vaccination against measles could prevent many more cases of the disease, known as subacute sclerosing panencephalitis, or SSPE, than previously thought.

Because persons have apparently contracted SSPE without ever knowingly having had measles, it could not be ruled out that the measles vaccine strain caused the infection. William Bellini, PhD, and colleagues at the Centers for Disease Control and Prevention (CDC), sought to evaluate that notion.

Brain tissue specimens from 11 patients suspected of having SSPE were examined. Five of the 11 patients with samples and 7 additional SSPE patients identified in case reports were related to infections during the resurgence of measles in the United States during a drop in measles vaccination rates between 1989 and 1991. The ages of the patients ranged from 5 to 36 years, with a mean of 14.

The researchers discovered wild-type measles virus in brain tissues from individuals with SSPE who had no previous diagnosis of measles and had been vaccinated. Case histories and demographics, when available, suggested that most of the individuals had very likely contracted measles prior to being vaccinated.

The fact that 12 SSPE patients identified in the study had measles between 1989 and 1991 raises the incidence of measles-induced SSPE to a level approximately 10 times higher than the statistic often cited. That figure, based on data available in 1982, estimated that 8.5 in 1 million persons contracted SSPE, a rate grossly underestimating the risk, now thought to be between 7 and 11 per 100,000.

The higher incidence could be due to an underreporting of diagnosed measles cases, despite clinical guidelines on reporting infections. Other possibilities include a higher incidence of measles during the 1989-1991 resurgence in the population with the highest risk for SSPE, namely children under the age of five, or because wild-type viruses of the genotype identified are more likely to cause SSPE.

The measles vaccine is known to be highly effective. Two doses provide immunity to 99 percent of those vaccinated. Since the risk of SSPE was much higher than originally estimated, and since the vaccine had not caused SSPE in the cases studied, the researchers concluded that measles vaccination programs prevent many more of the fatal brain infections than previously thought.

In an accompanying editorial, Samuel L Katz, MD, of Duke University, who was part of the team that developed the measles vaccine, strongly urged support for global efforts to reduce measles mortality through immunization programs. Despite recent reductions in the worldwide toll of measles, he noted, the disease still accounts for almost half of the 1.6 million annual childhood deaths due to vaccine-preventable diseases.


'"/>

Source:Infectious Diseases Society of America


Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/25/2016)... 25, 2016   Unisys Corporation (NYSE: UIS ) ... Kennedy (JFK) International Airport, New York City , ... imposters attempting to enter the United States ... pilot testing of the system at Dulles last ... at JFK during January 2016. --> pilot testing ...
(Date:1/22/2016)... , Jan. 22, 2016 ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics Market in Retail ... --> Research and Markets ...
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... February 11, 2016 , ... ... 150 years, continues today to pursue the highest level of accuracy and quality ... the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and tough enough ...
(Date:2/10/2016)... , Feb. 10, 2016  The Maryland House of ... has announced that University of Maryland School of Medicine ... and University of Maryland Medical System President and CEO ... "Speaker,s Medallion," the highest honor given to the public ... Dean Reece and Mr. Chrencik for ...
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... that Brent Saunders , Allergan,s CEO and President, ... fireside chat session at the RBC Capital Markets Healthcare ... ET at The New York Palace Hotel in ... be webcast live and can be accessed on Allergan,s ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare Medical, LLC reports the ... Sonalinkā„¢ remote monitoring. The inaugural launch of this new technology occurred over the ... Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters. , ...
Breaking Biology Technology: